#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	20904	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2100	974.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	1212	C	1181	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	38286	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3518	1071.2	0	.	n	.	0	A20C	SNP	20	20	A	322	322	C	663	C,A	645,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	38286	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3518	1071.2	0	.	n	.	0	T695C	SNP	695	695	T	997	997	C	1190	C	1169	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	38286	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3518	1071.2	0	.	n	.	0	A1638G	SNP	1638	1638	A	1940	1940	G	1290	G,A	1250,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	38286	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3518	1071.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2273	2273	C	1194	C,T,G,A	1161,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	38286	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3518	1071.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2347	2347	A	1234	A,T	1206,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	38286	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3518	1071.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2899	2899	C	1147	C,T,A	1114,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	38286	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3518	1071.2	0	HET	.	.	.	A412G	.	412	412	A	714	714	A	1217	A,G	876,279	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	8	blaTEM	861	357	100.0	blaTEM.l15.c30.ctg.1	357	2.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2702	folP	855	855	100.0	folP.l15.c4.ctg.1	1528	173.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1082	1084	AGC	263;267;271	A;G;C	261;264;266	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7826	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3504	219.2	1	SNP	p	S91F	1	.	.	271	273	TTC	632	634	TTC	264;266;269	T;T;C	259;262;264	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7826	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3504	219.2	1	SNP	p	G95N	0	.	.	283	285	GGC	644	646	GGC	262;263;260	G;G;C	256;258;256	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7826	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3504	219.2	1	SNP	p	D95G	1	.	.	283	285	GGC	644	646	GGC	262;263;260	G;G;C	256;258;256	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2506	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1402	175.3	0	.	p	.	0	F184L	NONSYN	550	552	TTC	937	939	TTG	246;242;246	T;T;G,A	240;240;243,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	2506	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1402	175.3	1	SNP	p	G45D	0	.	.	133	135	GGC	520	522	GGC	302;300;299	G;G;C	296;291;290	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1290	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1190	106.3	0	.	n	.	0	A197.	DEL	197	197	A	762	762	A	301	A	296	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6808	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3087	217.0	1	SNP	p	D86N	0	.	.	256	258	GAC	630	632	GAC	286;286;286	G;A;C	282;272;282	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6808	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3087	217.0	1	SNP	p	R87I	0	.	.	259	261	CGT	633	635	CGT	284;284;287	C,T;G;T	278,1;280;280	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6808	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3087	217.0	1	SNP	p	S87R	1	.	.	259	261	CGT	633	635	CGT	284;284;287	C,T;G;T	278,1;280;280	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6808	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3087	217.0	1	SNP	p	R87W	0	.	.	259	261	CGT	633	635	CGT	284;284;287	C,T;G;T	278,1;280;280	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6808	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3087	217.0	1	SNP	p	S88P	0	.	.	262	264	TCC	636	638	TCC	287;287;282	T,A;C;C	284,1;285;280	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5788	parE	1986	1986	100.0	parE.l15.c30.ctg.1	2711	210.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1605	1607	GGC	274;269;269	G;G;C,A	265;260;258,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1282	1284	GCA	308;306;310	G;C;A	301;294;305	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1285	1287	ATC	309;308;307	A;T;C	303;299;298	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1297	1299	GTG	326;326;324	G,T;T;G	317,1;316;318	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1297	1299	GTG	326;326;324	G,T;T;G	317,1;316;318	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1801	1803	ACC	267;264;265	A;C;C,T	260;261;261,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1855	1857	GCG	250;249;246	G,T;C,G;G	236,1;203,5;224	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1855	1857	GCG	250;249;246	G,T;C,G;G	236,1;203,5;224	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1978	1980	AGC	216;215;212	A;G,T;C	208;208,1;205	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1987	1989	GGC	200;197;195	G;G;C	193;190;183	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	5282	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2488	208.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2005	2007	CCG	151;156;154	C,G;C,G;G,T	135,1;141,2;136,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	8144	ponA	2397	2397	99.92	ponA.l15.c4.ctg.1	3133	255.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3328	porA	1146	1146	99.83	porA.l6.c30.ctg.1	1937	167.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	617	617	C	207	C	191	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	445	447	GAA	305;303;304	G;A;A	295;295;297	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	856	858	TCA	310;309;305	T;CAAA,CAA;A	301;296,1;299	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	985	987	GTC	290;289;286	G;T;C	287;279;284	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	0	.	p	.	0	F222S	NONSYN	664	666	TTT	997	999	TCT	293;294;296	T;C;T	290;291;295	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1315	1317	GCA	325;328;330	G;C,A;A	321;324,1;328	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	1	SNP	p	G120K	1	.	.	358	360	AAG	691	693	AAG	310;310;308	A,G;A,G;G,T,C,A	299,1;303,1;294,1,1,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	1	SNP	p	A121D	1	.	.	361	363	GAC	694	696	GAC	309;305;307	G;A,C;C	301;295,1;297	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3908	porB1b	1047	1047	99.24	porB1b.l15.c4.ctg.1	1549	248.4	1	SNP	p	D121N	0	.	.	361	363	GAC	694	696	GAC	309;305;307	G;A,C;C	301;295,1;297	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	13464	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5068	261.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1576	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1098	141.5	1	SNP	p	V57M	1	.	.	169	171	ATG	585	587	ATG	312;314;312	A;T;G	304;306;305	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
